Molecule Information
General Information of the Molecule (ID: Mol01963)
| Name |
Sclerostin (SOST)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
SOST; UNQ2976/PRO7455/PRO7476
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
SOST
|
||||
| Gene ID | |||||
| Location |
chr17:43,753,738-43,758,791[-]
|
||||
| Sequence |
MQLPLALCLVCLLVHTAFRVVEGQGWQAFKNDATEIIPELGEYPEPPPELENNKTMNRAE
NGGRPPHHPFETKDVSEYSCRELHFTRYVTDGPCRSAKPVTELVCSGQCGPARLLPNAIG RGKWWRPSGPDFRCIPDRYRAQRVQLLCPGGEAPRARKVRLVASCKCKRLTRFHNQSELK DFGTEAARPQKGRKPRPRARSAKANQAELENAY Click to Show/Hide
|
||||
| Function |
Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Anaplastic thyroid cancer | [1] | |||
| Sensitive Disease | Anaplastic thyroid cancer [ICD-11: 2D10.2] | |||
| Sensitive Drug | Pyrvinium | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | Wnt signaling pathway | Activation | hsa04310 | |
| In Vitro Model | LNCaP cells | Prostate | Homo sapiens (Human) | CVCL_0395 |
| HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |
| Experiment for Molecule Alteration |
Western blotting analysis; ART sensitivity assay | |||
| Experiment for Drug Resistance |
CCK-8 cell proliferation assay; Flow cytometry | |||
| Mechanism Description | Pyrvinium pamoate can overcome artemisinin's resistance in anaplastic thyroid cancer. The resistance of CAL-62 to ART was related to the upregulation of the WNT signaling pathway. | |||
Disease- and Tissue-specific Abundances of This Molecule
ICD Disease Classification 02
| Differential expression of molecule in resistant diseases | ||
| The Studied Tissue | Thyroid | |
| The Specified Disease | Thyroid cancer | |
| The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 7.33E-05; Fold-change: -1.02E-01; Z-score: -1.70E-01 | |
| The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 6.99E-02; Fold-change: -4.74E-02; Z-score: -1.25E-01 | |
|
Molecule expression in the normal tissue adjacent to the diseased tissue of patients
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
| Disease-specific Molecule Abundances |
|
Click to View the Clearer Original Diagram |
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
